大流行防范：开发针对 COVID-19 的疫苗和治疗性抗体。
Pandemic Preparedness: Developing Vaccines and Therapeutic Antibodies For COVID-19.
机构信息
Department of Medicine, Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA; Department of Pathology, Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.
Department of Surgery, Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.
出版信息
Cell. 2020 Jun 25;181(7):1458-1463. doi: 10.1016/j.cell.2020.05.041. Epub 2020 May 27.
The SARS-CoV-2 pandemic that causes COVID-19 respiratory syndrome has caused global public health and economic crises, necessitating rapid development of vaccines and therapeutic countermeasures. The world-wide response to the COVID-19 pandemic has been unprecedented with government, academic, and private partnerships working together to rapidly develop vaccine and antibody countermeasures. Many of the technologies being used are derived from prior government-academic partnerships for response to other emerging infections.
导致 COVID-19 呼吸道综合征的 SARS-CoV-2 大流行已造成全球公共卫生和经济危机，这需要快速开发疫苗和治疗对策。全世界对 COVID-19 大流行的反应是前所未有的，政府、学术和私营部门合作共同迅速开发疫苗和抗体对策。正在使用的许多技术都源自以前政府与学术界合作应对其他新出现感染的技术。
Zotero 插件